The Association Between the Rate of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers Use and the Number of Covid-19 Confirmed Cases and Deaths in the United States: Geospatial Study

Kyle Johnson, Maedeh Khayyat-Kholghi, Blake Johnson, Larisa G. Tereshchenko
doi: https://doi.org/10.1101/2020.05.31.20118802

Article Information

doi 
https://doi.org/10.1101/2020.05.31.20118802
History 
  • June 20, 2020.

Article Versions

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.

Author Information

  1. Kyle Johnson, BS1,*,
  2. Maedeh Khayyat-Kholghi, DO, MSc1,*,
  3. Blake Johnson, MS2 and
  4. Larisa G. Tereshchenko, MD, PhD.1,†
  1. 1Knight Cardiovascular Institute, Oregon Health & Science University, Portland, OR
  2. 2Flexport, San Francisco, CA
  1. ↵†Correspondence: Larisa Tereshchenko, 3181 SW Sam Jackson Park Rd; UHN62; Portland, OR, 97239. E-mail:tereshch{at}ohsu.edu. Phone:503-494-7400; Fax:503-494-8550.

  1. ↵* Equal author contribution

Back to top
Posted June 20, 2020.
Download PDF
Data/Code
Email
The Association Between the Rate of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers Use and the Number of Covid-19 Confirmed Cases and Deaths in the United States: Geospatial Study
Kyle Johnson, Maedeh Khayyat-Kholghi, Blake Johnson, Larisa G. Tereshchenko
medRxiv 2020.05.31.20118802; doi: https://doi.org/10.1101/2020.05.31.20118802
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area